Back to all news

DeepHealth Secures FDA Clearance for Breast Ultrasound AI

AuntMinnieIndustry

DeepHealth's AI breast ultrasound software receives FDA clearance, promising improved lesion detection and workflow.

Key Details

  • 1DeepHealth Breast Ultrasound AI achieves FDA 510(k) clearance.
  • 2The software automates detection, characterization, and reporting of breast lesions.
  • 3Validated at over 98% localization accuracy for breast lesions.
  • 4Reported 8% increase in sensitivity for breast cancer detection.
  • 5Radiologist interpretation time reduced by 37%.
  • 6Product to be rolled out across RadNet's imaging centers by year-end.

Why It Matters

This clearance brings a validated AI tool into the clinical workflow, enhancing detection accuracy and efficiency in breast ultrasound exams. Adoption may improve patient outcomes and reduce radiologist workload.

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.